Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 38.40
0.00 (0.00%)
Mar 4, 2026, 9:34 AM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 90.17 million as of March 4, 2026. Its market cap has decreased by -4.71% in one year.
Market Cap
90.17M
Enterprise Value
74.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
38.40
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 90.17M, a decrease of -54.39%. That is a compound annual growth rate of -15.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 90.17M | -2.83% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | 197.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 134.98M |
| IRLAB Therapeutics AB | 131.82M |
| Active Biotech AB | 126.53M |
| Xbrane Biopharma AB | 122.00M |
| Alligator Bioscience AB | 102.73M |
| Annexin Pharmaceuticals AB | 102.36M |
| Biovica International AB | 101.59M |
| Scandinavian ChemoTech AB | 89.09M |